Effect of Linagliptin on Glycemic Control in Chinese Patients with Newly-Diagnosed, Drug-Naïve Type 2 Diabetes Mellitus: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Effect of Linagliptin on Glycemic Control in Chinese Patients with Newly-Diagnosed, Drug-Naïve Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Published:2015 Issue: Volume:21 Page:2678-2684
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Wu Wenjun¹,Li Ying²,Chen Xiong¹,Lin Dini¹,Xiang Songying³,Shen Feixia¹,Gu Xuemei¹

Affiliation:

1. Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China (mainland)

2. Clinical Teaching Affairs Office, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China (mainland)

3. Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of Linagliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials;Therapeutic Innovation & Regulatory Science;2024-04-18

2. Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-11-30

3. Comparative analysis of the efficacies of probiotic supplementation and glucose-lowering drugs for the treatment of type 2 diabetes: A systematic review and meta-analysis;Frontiers in Nutrition;2022-07-18

4. Genome-Wide Transcriptome Analysis in Type 2 Diabetes Patients Treated by Sitagliptin;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-06

5. Development and evaluation of extended release metformin pellets suspended in teneligliptin jelly for the treatment of diabetes mellitus;Journal of Drug Delivery Science and Technology;2022-04